Protein Cell, 2021, 12(10):818-823

Molecular deconvolution of the neutralizing antibodies induced by an inactivated SARS-CoV-2 virus vaccine.

The rapid emergence and persistence of the pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has had enormous impacts on global health and the economy. Effective vaccines against SARS-CoV-2 are urgently needed to control the coronavirus disease 2019 (COVID-19) pandemic, and multiple vaccines have been found to be efficacious in preventing symptomatic COVID-19(Polack et al., 2020; Wu et al., 2020; Jones and Roy, 2021). We have developed a traditional beta-propiolactone-inactivated aluminum hydroxide-adjuvanted whole-virion SARS-CoV-2 vaccine (BBIBP-CorV), which elicited protective immune responses in clinical trials (Wang et al., 2020; Xia et al., 2021). The vaccine has been granted conditional approvals or emergency use authorizations (EUAs) in China and other countries.

Zhou X, Wang H, Ji Q, Du M, Liang Y, Li H, Li F, Shang H, Zhu X, Wang W, Jiang L, Stepanov AV, Ma T, Gong N, Jia X, Gabibov AG, Lou Z, Lu Y, Guo Y, Zhang H, Yang X

Laboratory of biocatalysis

: 10.1007/s13238-021-00840-z
Scopus: 2-s2.0-85105422823
: 33909239
IBCH: 9207
Ссылка на статью в журнале: https://link.springer.com/10.1007/s13238-021-00840-z
Кол-во цитирований на 06.2024: 10
Данные статьи проверены модераторами 2021-05-02

Список научных проектов, где отмечена публикация

  1. -Структурные и кинетические особенности презентации антигенов как ключ к пониманию механизмов индукции аутоиммунных патологий и лимфомогенезиса (July 1, 2017 — June 30, 2023). Gabibov A.G.. Grant, RSF.